Cyclodextrin News

July 9, 2019 CD as API / Events / Pharma applications

National Niemann Pick Disease Family Conference

The annual National Niemann Pick Disease Family Conference will be held on August 15-18, 2019, in Bloomington, US. The conference

July 2, 2019 CD as API / Pharma applications

Methyl-β-cyclodextrin, an actin depolymerizer augments the antiproliferative potential of microtubule-targeting agents

The effect of Methyl BCD (RAMEB) on cytoskeleton was studied. It was found that disassembling the actin network did not

June 26, 2019 CD as API / CD derivatives / Pharma applications

Clinical trial on Noninfectious Anterior Uveitis – SBECD offering disease resolution

Aldeyra Therapeutics Announced Results from the SOLACE Trial in Noninfectious Anterior Uveitis. The main points are: Statistical Significance Not Achieved

June 24, 2019 CD as API / Pharma applications

Antinociceptive effect of methyl BCD in drug-induced neuropathy

Lin et al. have recently reported on the mechanism of pain development and manipulation by methyl BCD [1]. A mouse

June 7, 2019 CD as API / CD derivatives

NO-delivering fluorescent beta-cyclodextrin polymer

A novel water-soluble β-cyclodextrin branched polymer covalently integrating a fluorescein moiety and a nitric oxide (NO) photodonor within its macromolecular

June 6, 2019 CD as API / CD derivatives / E-ducation

Carbohydrate drugs (Part 5) (Oligosaccharides, cyclodextrins)

First let’s talk about one of the biggest achievements in the history of cyclodextrin research: Sugammadex. Sugammadex (SGM) (BridionTM) (1a)

May 30, 2019 CD as API / CD derivatives

Lactosyl-β-cyclodextrin against Hepatomegaly in Niemann-Pick Type C Disease

The first paper in the special issue of Nanomaterials “Nanoconstructs Based on Cyclodextrins” has been published. Mono-lactosyl β-CD (mono-Lac-β-CD) diminished